Thermo Fisher Scientific (TMO) News Today

Natixis lessened its stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 99.2% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,429 shares of the medical research company's stock after selling 178,765 shar

Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) - Analysts at Leerink Partnrs dropped their Q3 2024 earnings per share estimates for Thermo Fisher Scientific in a research note issued to investors on Wednesday, July 24th. Leerink Partnrs analyst P. Souda now anticipates that the medical re

TD Cowen lifted their target price on shares of Thermo Fisher Scientific from $648.00 to $658.00 and gave the company a "buy" rating in a research report on Thursday.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) released its quarterly earnings results on Wednesday. The medical research company reported $5.37 EPS for the quarter, topping analysts' consensus estimates of $5.13 by $0.24. Thermo Fisher Scientific had a net margin of 14.20% and a return on equity of 18.45%. The firm had revenue of $10.54 billion during the quarter, compared to analysts' expectations of $10.50 billion. During the same period in the previous year, the company earned $5.15 EPS. The firm's revenue for the quarter was down 1.4% compared to the same quarter last year.

Lake Street Advisors Group LLC increased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 105.1% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 4,042 shares of the medical research company's stock after purchasing an additiona

Thermo Fisher Scientific (NYSE:TMO) updated its FY24 earnings guidance. The company provided EPS guidance of $21.29-22.07 for the period, compared to the consensus estimate of $21.69. The company also issued revenue guidance of $42.4-43.3 billionillion, compared to the consensus estimate of $42.96 billionillion.

Thermo Fisher Scientific (NYSE:TMO) updated its FY 2024 earnings guidance. The company provided EPS guidance of 21.290-22.070 for the period, compared to the consensus estimate of 21.700. The company also issued revenue guidance of $42.4 billionillion-$43.3 billionillion, compared to the consensus estimate of $43.0 billionillion.

O Shaughnessy Asset Management LLC grew its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 26.5% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 22,592 shares of the medical research company's stock after buying an additional

Edgestream Partners L.P. purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 2,858 shares of the medical research company's stock,

Connors Investor Services Inc. acquired a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 11,755 shares o

M&G Plc purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 156,543 shares of the medical research company's stock,

Lord Abbett & CO. LLC increased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 1.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 78,247 shares of the medical research company's stock after acq

BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 0.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 183,156 shar

Thermo Fisher Scientific (NYSE:TMO) will be releasing earnings before the market opens on Wednesday, July 24, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=605864)

Thoroughbred Financial Services LLC trimmed its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 32.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,982 shares of the medical res

Choate Investment Advisors boosted its position in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 37.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,544 shares of the medic

Keating Investment Counselors Inc. trimmed its stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 28.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,595 shares of the medical research com

Empowered Funds LLC boosted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 53.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,704 shares of the medical research company's s

Envestnet Portfolio Solutions Inc. lifted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 30.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 45,451 shares of the medical research compa

Advisors Capital Management LLC grew its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 5.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 111,169 shares of the medical research company's stock

Thermo Fisher Scientific Inc. (NYSE:TMO) announced a quarterly dividend on Thursday, July 11th. Stockholders of record on Friday, September 13th will be paid a dividend of 0.39 per share by the medical research company on Tuesday, October 15th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.29%.

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eighteen brokerages that are presently covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation and thir

BI Asset Management Fondsmaeglerselskab A S lifted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 24.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,480 shares of the

Nordea Investment Management AB cut its stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 73.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 69,931 shares of the medical resea